Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. CME/CE

Mastering ARIA Management: Charting the Path in a Virtual Clinic

15 minutes
ReachMD Healthcare Image
Restart
Resume
Choose a format
Take Post-Test Skip straight to the post-test if you have already participated in this activity.
0.25 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    This simulation-based activity addresses a complex clinical scenario involving a patient with mild cognitive impairment due to Alzheimer’s disease. It is designed to enhance participants' diagnostic and decision-making skills, emphasizing the integration of multidisciplinary perspectives to optimize patient outcomes. Participants will navigate real-world complexities in therapeutic management, driving improvements in patient-centered care and supporting better health outcomes.

  • Disclosure of Conflicts of Interest

    DISCLOSURES —

    DR. BATEMAN REPORTED THE FOLLOWING FINANCIAL RELATIONSHIPS.

    Grants/Research Support: 
    Alzheimer’s Association; Dementia Alliance of North Carolina

    Consulting Fees: Medscape, NovoNordisk

  • Target Audience

    This activity is intended for neurologists, geriatric psychiatrists, geriatricians, and advanced practice providers who specialize in treating patients with Alzheimer’s disease.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Recognize symptoms of amyloid-related imaging abnormalities (ARIA) and determine appropriate next steps based on care setting and current recommendations.
    • Identify both proactive and reactive management strategies that have been employed for individual presentations of ARIA to maximize patient safety while minimizing therapeutic disruption.
  • Accreditation and Credit Designation Statements

    In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Efficient LLC. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    PHYSICIAN CREDIT 
    Medical Education Resources designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NURSING CREDIT
    Medical Education Resources designates this enduring material for a maximum of 0.25 ANCC nursing contact hours.  

    PHYSICIAN ASSOCIATES CREDIT
    Medical Education Resources has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.  This activity is designated for 0.25 AAPA Category 1 CME Credits.  Physician Associates should only claim credit commensurate with the extent of their participation.

    CERTIFICATE OF PARTICIPATION FOR OTHER HEALTHCARE PROFESSIONALS
    A Certificate of Participation will be given upon completion of the enduring activity enabling participants to register their credit with the appropriate licensing boards or associations.

  • Disclaimer

    Disclosure of Relevant Financial Relationships
    Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.

    All relevant conflicts of interest have been mitigated prior to the start of the activity.
    Efficient LLC and Medical Education Resources' planners and managers have no financial relationships to disclose. 

    Disclaimer
    The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Efficient LLC, and/or Lilly. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

    Method of Participation
    There are no fees for participating in and receiving credit for this activity. During the period December 20, 2024 through December 20, 2025, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by recording the best answer to each question, and 4) complete the evaluation form.

    Media
    Internet

  • Provider(s)/Educational Partner(s)

    This activity is jointly provided by Medical Education Resources (MER) and Efficient LLC.

  • Commercial Support

    This activity is supported by an educational grant from Lilly. 

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Recommended
Details
Presenters
Comments
  • Overview

    This simulation-based activity addresses a complex clinical scenario involving a patient with mild cognitive impairment due to Alzheimer’s disease. It is designed to enhance participants' diagnostic and decision-making skills, emphasizing the integration of multidisciplinary perspectives to optimize patient outcomes. Participants will navigate real-world complexities in therapeutic management, driving improvements in patient-centered care and supporting better health outcomes.

  • Disclosure of Conflicts of Interest

    DISCLOSURES —

    DR. BATEMAN REPORTED THE FOLLOWING FINANCIAL RELATIONSHIPS.

    Grants/Research Support: 
    Alzheimer’s Association; Dementia Alliance of North Carolina

    Consulting Fees: Medscape, NovoNordisk

  • Target Audience

    This activity is intended for neurologists, geriatric psychiatrists, geriatricians, and advanced practice providers who specialize in treating patients with Alzheimer’s disease.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Recognize symptoms of amyloid-related imaging abnormalities (ARIA) and determine appropriate next steps based on care setting and current recommendations.
    • Identify both proactive and reactive management strategies that have been employed for individual presentations of ARIA to maximize patient safety while minimizing therapeutic disruption.
  • Accreditation and Credit Designation Statements

    In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Efficient LLC. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    PHYSICIAN CREDIT 
    Medical Education Resources designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NURSING CREDIT
    Medical Education Resources designates this enduring material for a maximum of 0.25 ANCC nursing contact hours.  

    PHYSICIAN ASSOCIATES CREDIT
    Medical Education Resources has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.  This activity is designated for 0.25 AAPA Category 1 CME Credits.  Physician Associates should only claim credit commensurate with the extent of their participation.

    CERTIFICATE OF PARTICIPATION FOR OTHER HEALTHCARE PROFESSIONALS
    A Certificate of Participation will be given upon completion of the enduring activity enabling participants to register their credit with the appropriate licensing boards or associations.

  • Disclaimer

    Disclosure of Relevant Financial Relationships
    Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.

    All relevant conflicts of interest have been mitigated prior to the start of the activity.
    Efficient LLC and Medical Education Resources' planners and managers have no financial relationships to disclose. 

    Disclaimer
    The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Efficient LLC, and/or Lilly. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

    Method of Participation
    There are no fees for participating in and receiving credit for this activity. During the period December 20, 2024 through December 20, 2025, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by recording the best answer to each question, and 4) complete the evaluation form.

    Media
    Internet

  • Provider(s)/Educational Partner(s)

    This activity is jointly provided by Medical Education Resources (MER) and Efficient LLC.

  • Commercial Support

    This activity is supported by an educational grant from Lilly. 

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Schedule21 Dec 2024